ARBORETUM VENTURES, LLC
ARBORETUM VENTURES, LLC is a Series A, Series B and Series C+ fund in the US and US Midwest writing $8M–$12M checks into medical-devices, life-science-tools, diagnostics, tech-enabled-care-delivery, healthcare-it and pharma-adjacencies.
- Stages
- Series A, Series B, Series C+
- Sectors
- medical-devices, life-science-tools, diagnostics, tech-enabled-care-delivery, healthcare-it, pharma-adjacencies
- Check size
- $8M–$12M
- Invests in
- US-wide, US Midwest
- Actively investing
- Yes
- Founded
- 2002
- Assets under management
- $974M
Thesis
Arboretum Ventures, LLC, founded in 2002 and based in Ann Arbor, Michigan, is a venture capital firm specializing in the healthcare sector. With approximately $1 billion raised across multiple funds and AUM around $974 million, their investment thesis focuses on improving patient outcomes and reducing healthcare costs. They primarily target early-stage companies (Series A and B, but also C and beyond) in areas such as medical devices, life science tools & diagnostics, tech-enabled care delivery, healthcare IT, and pharma adjacencies. Geographically, they focus on North America, with a preference for the US Midwest. Their preferred initial investment is between $8 million and $12 million, with some recent deals ranging from $10 million to $68 million.
Common questions
Does ARBORETUM VENTURES, LLC invest at the Series A stage?
Yes. ARBORETUM VENTURES, LLC lists Series A, Series B and Series C+ among the stages it invests in.
What check size does ARBORETUM VENTURES, LLC write?
ARBORETUM VENTURES, LLC writes $8M–$12M checks.
Where does ARBORETUM VENTURES, LLC invest?
ARBORETUM VENTURES, LLC invests in the US and US Midwest.